Disclosure Panels Details Page
Skin Cancers Excluding Melanoma Panel - Disclosures as of 07/20/2021
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Sumaira Aasi MD | None | None | None | None | - |
| Murad Alam MD, MBA, MSCI | None | None | None | None | - |
| James Andersen MD | None | None | None | None | - |
| Brian Baumann MD | None | Regeneron Pharmaceuticals, Inc. | Mevion Medical Systems | Myovant Sciences | ✔ |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| Rachel Blitzblau MD, PhD | None | None | None | None | - |
| Jeremy Bordeaux MD, MPH | None | None | None | None | ✔ |
| Pei-Ling Chen MD, PhD | None | None | None | None | - |
| Robert Chin MD, PhD | AstraZeneca Pharmaceuticals LP Eli Lilly and Company Varian Medical Systems, Inc. |
None | None | None | ✔ |
| Carlo Contreras MD | National Cancer Institute The Ohio State University Innovation Studio |
Rasansky Law Firm | Gerson Lehrman Group | None | ✔ |
| Dominick DiMaio MD | None | None | None | None | ✔ |
| Jessica Donigan MD | Castle Biosciences | None | None | None | ✔ |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Jeffrey Farma MD | Delcath | None | None | None | ✔ |
| Karthik Ghosh MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Roy Grekin MD | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Kelly Harms MD, PhD | OncoSec | None | None | None | ✔ |
| Stephanie Helbling MPH, CHES | None | None | None | None | - |
| Alan Ho MD, PhD | Affyimmune Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Ayala Pharmaceuticals Bayer HealthCare Bristol Myers Squibb Eisai Inc. Elevar GSK Hookipa Kura Oncology, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Regeneron Pharmaceuticals, Inc. |
Eisai Inc. Exelixis Inc. Inxmed Kura Oncology, Inc. Rgenta |
None | International Thyroid Oncology Group|Rgenta | ✔ |
| Anne Holbrook PharmD, BCOP | None | None | None | None | ✔ |
| Ashley Holder MD | None | None | None | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | ✔ |
| John Nicholas Lukens MD | None | None | None | None | ✔ |
| Beth McCullough RN, BS, CMSRN | None | None | None | None | ✔ |
| Theresa Medina MD | Bristol Myers Squibb Merck & Co., Inc. Nektar Therapeutics Pfizer Inc. |
None | None | None | ✔ |
| Kishwer Nehal MD | None | None | None | None | - |
| Paul Nghiem MD, PhD | Bristol Myers Squibb EMD Serono |
EMD Serono Pfizer Inc. |
None | Society for investigative dermatology | ✔ |
| Mai Nguyen PhD | None | None | None | None | ✔ |
| Soo Park MD | None | Regeneron Pharmaceuticals, Inc. | None | None | ✔ |
| Tejesh Patel MD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Igor Puzanov MD, MSCI, FACP | Amgen Inc. AstraZeneca Pharmaceuticals LP Nektar Therapeutics |
Merck & Co., Inc. SOTIO, LLC |
None | Celldex Therapeutics | ✔ |
| Chrysalyne Schmults MD, MS | Castle Bioscience Genentech, Inc. InflaRX Merck & Co., Inc. Novartis Pharmaceuticals Corporation Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. SCOUT CONSORTIUM |
Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. SCOUT |
None | None | - |
| Jeffrey Scott MD, MHS | None | None | None | None | ✔ |
| Aleksandar Sekulic MD, PhD | Regeneron Pharmaceuticals, Inc. | None | None | None | - |
| Ashok Shaha MD | None | None | None | None | - |
| Divya Srivastava MD | Regeneron Pharmaceuticals, Inc. | None | None | None | - |
| William Stebbins MD | None | None | None | None | ✔ |
| Valencia Thomas MD | None | Merck & Co., Inc. Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Amanda Visnick BSN, RN, OCN | None | None | None | None | ✔ |
| Yaohui Gloria Xu MD, PhD | None | None | None | None | ✔ |